TELA · TELA BIO INC
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Market Cap
48.75M
52 Wk Range
$0.50 - $1.56
Previous Close
$1.08
Open
$1.08
Volume
60,936
Day Range
$1.03 - $1.15
Enterprise Value
84.87M
Cash
30.42M
Avg Qtr Burn
-9.381M
Insider Ownership
7.11%
Institutional Own.
63.29%
Qtr Updated
Jun 30th 2026
